The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

Share Price Information for Saint Gobain Or (COD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 79.775
Bid: 75.80
Ask: 83.75
Change: 1.675 (2.14%)
Spread: 7.95 (10.488%)
Open: 78.10
High: 0.00
Low: 0.00
Prev. Close: 78.10
COD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

4 Jan 2023 07:10

RNS Number : 6310L
Compagnie de Saint-Gobain
04 January 2023
 

 

 

 

 

SAINT-GOBAIN STRENGTHENS its presence in construction chemicals, with the acquisitions of

matchem in brazil and IDP Chemicals in egypt

 

Saint-Gobain, through its Chryso business, has completed the acquisition of Matchem in Brazil and entered into exclusive negotiations to acquire IDP Chemicals in Egypt.

 

The acquisitions of Matchem and IDP Chemicals will allow Saint-Gobain to strengthen its position in construction chemicals, in particular concrete admixtures which play a key role in the decarbonization of the construction industry. These two companies are focused on the buoyant building and infrastructure markets in Brazil and Egypt, which should see strong growth for the years to come.

 

Matchem, established in 2011, employs around 50 people across two plants in Brazil and generated revenues of close to €20 million in 2022. Together with Quartzolit, leader in mortars (tile fixings, wall and floor coatings, waterproofing membranes), TekBond, sealant and adhesive specialist, and the recently acquired GCP Applied Technologies, Matchem will reinforce Saint-Gobain's platform in construction chemicals, a leader on the Brazilian market with 24 industrial sites.

 

IDP Chemicals, licensed by Chryso since 2018, employs 25 people at one plant and is well positioned to serve the dynamic construction market in Egypt. This acquisition should be finalized in the first quarter of 2023.

 

Chryso benefits from Saint-Gobain's strong presence in Brazil and Egypt to accelerate its inorganic growth strategy. Matchem and IDP Chemicals will be consolidated within the Construction Chemicals segment in High Performance Solutions.

 

The acquisitions of Matchem and IDP Chemicals are in line with Saint-Gobain's "Grow & Impact" strategy aiming to both strengthen the Group's leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

 

ABOUT SAINT-GOBAIN

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufacturesand distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonizationof construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose,"MAKING THE WORLD A BETTER HOME".

 

€44.2 billion in sales in 2021

166,000 employees, locations in 76 countries

Committed to achieving Carbon Neutrality by 2050

 

For more information about Saint-Gobain,visit www.saint-gobain.com and follow us on Twitter @saintgobain

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBIMRTMTMMMFJ
Date   Source Headline
29th Oct 20144:45 pmRNSNew plant
27th Oct 20144:58 pmRNSNew plant
27th Oct 20147:56 amRNSAcquisition
23rd Oct 20144:46 pmRNS3rd Quarter Results
15th Sep 20146:30 pmRNSFinal Terms
5th Sep 20148:01 amRNSJV Saint-Gobain Central Glass in Indonesia
8th Aug 20144:07 pmRNSProspectus supplement
1st Aug 20148:34 amRNSAcquisition
30th Jul 20145:27 pmRNSH1-2014 Results
28th Jul 20147:52 amRNSNew contracts in Qatar
18th Jul 20148:13 amRNSPublication of Prospectus
7th Jul 20145:43 pmRNSAgreement Saint-Gobain / EBRD
2nd Jul 20145:10 pmRNSResult of the 2013 scrip dividend
17th Jun 201410:25 amRNSAcquisition
5th Jun 20146:21 pmRNSAdoption of all resolutions & reappointment of CEO
3rd Jun 20148:15 amRNSJoin Venture
29th Apr 20145:03 pmRNS1st Quarter Results
11th Apr 20144:54 pmRNSDisposal
27th Mar 20149:22 amRNSDecision of the General Court of the EU
4th Mar 20149:19 amRNSProspectus Supplement
19th Feb 20146:08 pmRNSFinal Results
19th Dec 20134:46 pmRNSDisposal
17th Dec 20134:49 pmRNSundrawn bank facilities
4th Dec 20134:50 pmRNSAcquisition
2nd Dec 20134:46 pmRNSSecuritisation programme
28th Nov 20137:00 amRNSFinal Terms
28th Nov 20137:00 amRNSFinal Terms
27th Nov 20136:08 pmRNSInvestor Meeting
25th Nov 20137:00 amRNSFinal Terms
25th Nov 20137:00 amRNSFinal terms
25th Nov 20137:00 amRNSFinal Terms
22nd Nov 20137:00 amRNSDirector renewal
24th Oct 20134:46 pmRNS3rd Quarter Results
30th Sep 20135:53 pmRNSFinal Terms
30th Sep 20137:00 amRNSR&D Center
6th Aug 20137:00 amRNSProspectus supplement
31st Jul 20133:23 pmRNSH1-2013 Financial Report
24th Jul 20135:10 pmRNSHalf Year Results
18th Jul 20138:40 amRNSProspectus
11th Jul 201311:30 amRNSNew plant in Russia
3rd Jul 20134:58 pmRNS2012 dividend
2nd Jul 20138:34 amRNSDisposal
6th Jun 20136:34 pmRNSFinal Terms
6th Jun 20136:25 pmRNSAGM Statement
30th May 20131:28 pmRNSCORRECTIONS TO FINAL TERMS
25th Apr 20135:16 pmRNS1st Quarter Results
9th Apr 20135:11 pmRNSContract in Kuwait
5th Apr 20132:43 pmRNSFinal Terms
5th Apr 20132:43 pmRNSFinal Terms
2nd Apr 201311:08 amRNSDoc Re: Prospectus Supplement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.